Profitable Growth Despite Challenges

In fiscal 2022, the Group delivered solid growth in net sales and EBITDA pre.

Key facts and Forecast

Results of fiscal 2022

  • Group net sales rise 12.9% to € 22.2 billion
  • EBITDA pre up 12.2% to € 6.8 billion
  • “Big 3” businesses generate almost 90% of organic sales growth
  • Dividend proposal: € 2.20 per share 

Forecast for fiscal 2023

  • Net sales: slight to solid organic growth
  • EBITDA pre: organically moderate decline to about stable
  • Negative foreign exchange effects expected

Overview: Business performance in fiscal 2022

 

Fiscal 2022              
(in € billion)

Change (in %, compared to fiscal 2021)

Organic growth (in %, compared to fiscal 2021)

Group net sales

22.2

12.9

6.4

EBITDA pre

6.8

12.2

6.1

Life Science sales

10.4

15.4

8.2

Healthcare sales

7.8

10.6

5.5

Electronics sales

4.0

11.3

3.7

Belén Garijo - Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany Belén Garijo - Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany

We delivered profitable growth in fiscal 2022 despite challenges.

Belén Garijo

Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany

Annual Reports Archive

Find previous Annual Reports, Corporate Governance Reports & Statements in our archive.
Read more

Conference calls for the media and analysts

  • The annual press conference and the conference call for analysts are available as a recording

Related News

View All News
  1. Press Releases

    Fiscal 2022: Merck KGaA, Darmstadt, Germany, Delivers Profitable Growth Despite ...

    Merck KGaA, Darmstadt, Germany delivered profitable growth despite challenges in fiscal 2022. Group net sales increased by 12.9% (organically: 6.4%) to € 22,232 million compared with the previous year.

    2023/03/02

Upcoming Events

View All Events

Esther Döringer

Media Relations

Constantin Fest

Head of Investor Relations

+49 6151 72-5271

+49 6151 72 91-5271

Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.

Check Share Price